Crystal Structure of Human Dihydrolipoamide Dehydrogenase: NAD+/NADH Binding and the Structural Basis of Disease-causing Mutations
- 25 May 2005
- journal article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 350 (3), 543-552
- https://doi.org/10.1016/j.jmb.2005.05.014
Abstract
Human dihydrolipoamide dehydrogenase (hE3) is an enzymatic component common to the mitochondrial α-ketoacid dehydrogenase and glycine decarboxylase complexes. Mutations to this homodimeric flavoprotein cause the often-fatal human disease known as E3 deficiency. To catalyze the oxidation of dihydrolipoamide, hE3 uses two molecules: non-covalently bound FAD and a transiently bound substrate, NAD+. To address the catalytic mechanism of hE3 and the structural basis for E3 deficiency, the crystal structures of hE3 in the presence of NAD+ or NADH have been determined at resolutions of 2.5 Å and 2.1 Å, respectively. Although the overall fold of the enzyme is similar to that of yeast E3, these two structures differ at two loops that protrude from the proteins and at their FAD-binding sites. The structure of oxidized hE3 with NAD+ bound demonstrates that the nicotinamide moiety is not proximal to the FAD. When NADH is present, however, the nicotinamide base stacks directly on the isoalloxazine ring system of the FAD. This is the first time that this mechanistically requisite conformation of NAD+ or NADH has been observed in E3 from any species. Because E3 structures were previously available only from unicellular organisms, speculations regarding the molecular mechanisms of E3 deficiency were based on homology models. The current hE3 structures show directly that the disease-causing mutations occur at three locations in the human enzyme: the dimer interface, the active site, and the FAD and NAD+-binding sites. The mechanisms by which these mutations impede the function of hE3 are discussed.Keywords
This publication has 33 references indexed in Scilit:
- Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutationEuropean Journal of Pediatrics, 2003
- Catalysis of Diaphorase Reactions by Mycobacterium tuberculosis Lipoamide Dehydrogenase Occurs at the EH4 LevelBiochemistry, 2003
- The glycine decarboxylase system: a fascinating complexTrends in Plant Science, 2001
- Crystal Structure of Eucaryotic E3, Lipoamide Dehydrogenase from YeastThe Journal of Biochemistry, 1998
- Targeted disruption of the murine dihydrolipoamide dehydrogenase gene ( Dld ) results in perigastrulation lethalityProceedings of the National Academy of Sciences of the United States of America, 1997
- Three-dimensional Structure of Lipoamide Dehydrogenase from Pseudomonas fluorescens at 2·8 Å Resolution: Analysis of Redox and Thermostability PropertiesJournal of Molecular Biology, 1993
- The refined crystal structure of Pseudomonas putida lipoamide dehydrogenase complexed with NAD+ at 2.45 Å resolutionProteins-Structure Function and Bioinformatics, 1992
- Refined crystal structure of lipoamide dehydrogenase from Azotobacter vinelandii at 2.2 Å resolutionJournal of Molecular Biology, 1991
- Mechanisms of flavoprotein‐catalyzed reactionsEuropean Journal of Biochemistry, 1989
- The mitochondrial glycine cleavage systemMolecular and Cellular Biochemistry, 1982